Literature DB >> 20112952

Pharmacophore screening of the protein data bank for specific binding site chemistry.

Valérie Campagna-Slater1, Andrew G Arrowsmith, Yong Zhao, Matthieu Schapira.   

Abstract

A simple computational approach was developed to screen the Protein Data Bank (PDB) for putative pockets possessing a specific binding site chemistry and geometry. The method employs two commonly used 3D screening technologies, namely identification of cavities in protein structures and pharmacophore screening of chemical libraries. For each protein structure, a pocket finding algorithm is used to extract potential binding sites containing the correct types of residues, which are then stored in a large SDF-formatted virtual library; pharmacophore filters describing the desired binding site chemistry and geometry are then applied to screen this virtual library and identify pockets matching the specified structural chemistry. As an example, this approach was used to screen all human protein structures in the PDB and identify sites having chemistry similar to that of known methyl-lysine binding domains that recognize chromatin methylation marks. The selected genes include known readers of the histone code as well as novel binding pockets that may be involved in epigenetic signaling. Putative allosteric sites were identified on the structures of TP53BP1, L3MBTL3, CHEK1, KDM4A, and CREBBP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112952     DOI: 10.1021/ci900427b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

Review 1.  Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.

Authors:  Pilar Blancafort; Jian Jin; Stephen Frye
Journal:  Mol Pharmacol       Date:  2012-11-13       Impact factor: 4.436

2.  Small-molecule ligands of methyl-lysine binding proteins.

Authors:  J Martin Herold; Tim J Wigle; Jacqueline L Norris; Robert Lam; Victoria K Korboukh; Cen Gao; Lindsey A Ingerman; Dmitri B Kireev; Guillermo Senisterra; Masoud Vedadi; Ashutosh Tripathy; Peter J Brown; Cheryl H Arrowsmith; Jian Jin; William P Janzen; Stephen V Frye
Journal:  J Med Chem       Date:  2011-03-18       Impact factor: 7.446

3.  Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?

Authors:  Aytug K Kiper; Susanne Rinné; Caroline Rolfes; David Ramírez; Guiscard Seebohm; Michael F Netter; Wendy González; Niels Decher
Journal:  Pflugers Arch       Date:  2014-12-17       Impact factor: 3.657

4.  Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis.

Authors:  Ke-Ying Fang; Gui-Ning Liang; Zhuo-Qing Zhuang; Yong-Xin Fang; Yu-Qian Dong; Chuang-Jia Liang; Xin-Yan Chen; Xu-Guang Guo
Journal:  J Clin Lab Anal       Date:  2022-06-03       Impact factor: 3.124

5.  Ligand binding site superposition and comparison based on Atomic Property Fields: identification of distant homologues, convergent evolution and PDB-wide clustering of binding sites.

Authors:  Maxim Totrov
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

6.  Evaluation of the antibacterial activity of patchouli oil.

Authors:  Xian Yang; Xue Zhang; Shui-Ping Yang; Wei-Qi Liu
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

7.  Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening.

Authors:  David Ramírez; Guierdy Concha; Bárbara Arévalo; Luis Prent-Peñaloza; Leandro Zúñiga; Aytug K Kiper; Susanne Rinné; Miguel Reyes-Parada; Niels Decher; Wendy González; Julio Caballero
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.